Physician and Patient-Reported Outcomes of the MC1635 Phase III Trial of Ultra-Hypofractionated Versus Moderate Hypofractionated Adjuvant Radiotherapy After Breast-Conserving Surgery

NRG RTOG 1005: A Phase III Trial of Hypo Fractionated Whole Breast Irradiation with Concurrent Boost vs. Conventional Whole Breast Irradiation Plus Sequential Boost Following Lumpectomy for High Risk Early-Stage Breast Cancer

(2022) F.A. Vicini et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial

(2021) Tobias Forster et al.   RADIOTHERAPY AND ONCOLOGY

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

(2020) Adrian Murray Brunt et al.   LANCET

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

(2020) Adrian Murray Brunt et al.   JOURNAL OF CLINICAL ONCOLOGY

Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial

(2020) Birgitte V. Offersen et al.   JOURNAL OF CLINICAL ONCOLOGY

Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial

(2020) Icro Meattini et al.   JOURNAL OF CLINICAL ONCOLOGY

Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)

(2020) Juliane Hörner-Rieber et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction

(2019) Meghan R. Flanagan et al.   ANNALS OF SURGICAL ONCOLOGY

Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial

(2018) Simona F. Shaitelman et al.   JOURNAL OF CLINICAL ONCOLOGY

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

(2016) A. Murray Brunt et al.   RADIOTHERAPY AND ONCOLOGY

Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial

(2015) Lorenzo Livi et al.   EUROPEAN JOURNAL OF CANCER

Choosing Wisely? Patterns and Correlates of the Use of Hypofractionated Whole-Breast Radiation Therapy in the State of Michigan

(2014) Reshma Jagsi et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

(2013) Joanne S Haviland et al.   LANCET ONCOLOGY

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

(2011)   LANCET

Is α/β for breast cancer really low?

(2011) X. Sharon Qi et al.   RADIOTHERAPY AND ONCOLOGY

Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

(2010) Timothy J. Whelan et al.   NEW ENGLAND JOURNAL OF MEDICINE

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

(2008)   LANCET